Inotiv, Inc. Common Stock
NOTVStock
$0.01−99.33%52W
Market Cap$418,658
P/E—
Div yield—
Beta3.99
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-106.65%
Price vs S&P 500 (4W)-63.49%
VGM Score52.36
Market Capitalization$418,658
Earnings Surprise History
Q2 26-0.94est. -0.65
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.13
4.13
4.13
4.13
Industry Peers — R&D — Physical Sciences(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NOTVInotiv, Inc. Common Stock | A | B | F | $0.01 |
| IQVIQVIA Holdings Inc. | C | C | B | $210.49 |
| INCYIncyte Genomics Inc | C | A | B | $116.65 |
| MEDPMedpace Holdings, Inc. Common Stock | F | B | B | $537.92 |
| ICLRIcon Plc | C | C | B | $170.00 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $229.16 |
| ABSIAbsci Corporation Common Stock | F | F | A | $8.23 |
| NRCNRC Health Common Stock | D | D | B | $21.94 |
| OABIOmniAb, Inc. Common Stock | D | C | B | $2.04 |
| MXCTMaxCyte, Inc. Common Stock | C | D | B | $1.35 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | C | $0.69 |
About
Inotiv provides nonclinical and analytical drug development services to pharmaceutical, chemical, and medical device companies. Operating through two segments—Discovery and Safety Assessment and Research Models and Services—the company supports small molecule and biologic drug discovery while supplying specialized research models for disease-specific applications. The Research Models and Services segment generates the majority of revenue.